Humana (HUM) Stock Overview
Provides medical and specialty insurance products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
HUM Community Fair Values
Create NarrativeSee what 113 others think this stock is worth. Follow their fair value or set your own to get alerts.
Humana Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$166.00 |
| 52 Week High | US$315.35 |
| 52 Week Low | US$163.11 |
| Beta | 0.42 |
| 1 Month Change | -12.88% |
| 3 Month Change | -35.92% |
| 1 Year Change | -37.26% |
| 3 Year Change | -67.47% |
| 5 Year Change | -59.82% |
| Change since IPO | 13,824.60% |
Recent News & Updates
Recent updates
Humana Inc. (NYSE:HUM) Might Not Be As Mispriced As It Looks After Plunging 30%
Feb 05
Humana: Market Is Right To Be Skeptical
Jan 29Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Dec 19Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Dec 05Humana (NYSE:HUM) Has Announced A Dividend Of $0.885
Nov 16Humana's (NYSE:HUM) Conservative Accounting Might Explain Soft Earnings
Nov 13Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Nov 02Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885
Aug 26Humana Inc. (NYSE:HUM) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Aug 15
Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Apr 30Humana Q4 Earnings Review: A Tough Quarter -- And A Rating Downgrade
Feb 12Humana's Growth Vs. Rising Costs: Why It's A Hold For Cautious Investors
Jan 10Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?
Dec 18Humana: Medicare Advantage Is Just A Short-Term Problem
Dec 05Humana - Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over
Nov 05Wall Street Lunch: Humana Shares Hit Hard
Oct 02Humana's Falling Share Price Gives Investors An Opportunity
Sep 18Shareholder Returns
| HUM | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -2.4% | -2.7% | -3.5% |
| 1Y | -37.3% | -28.8% | 14.0% |
Return vs Industry: HUM underperformed the US Healthcare industry which returned -28.8% over the past year.
Return vs Market: HUM underperformed the US Market which returned 14% over the past year.
Price Volatility
| HUM volatility | |
|---|---|
| HUM Average Weekly Movement | 8.0% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: HUM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HUM's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 67,060 | Jim Rechtin | www.humana.com |
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers.
Humana Inc. Fundamentals Summary
| HUM fundamental statistics | |
|---|---|
| Market cap | US$20.30b |
| Earnings (TTM) | US$1.19b |
| Revenue (TTM) | US$129.66b |
Is HUM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HUM income statement (TTM) | |
|---|---|
| Revenue | US$129.66b |
| Cost of Revenue | US$110.81b |
| Gross Profit | US$18.85b |
| Other Expenses | US$17.66b |
| Earnings | US$1.19b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 29, 2026
| Earnings per share (EPS) | 9.90 |
| Gross Margin | 14.54% |
| Net Profit Margin | 0.92% |
| Debt/Equity Ratio | 71.7% |
How did HUM perform over the long term?
See historical performance and comparisonDividends
Does HUM pay a reliable dividends?
See HUM dividend history and benchmarks| Humana dividend dates | |
|---|---|
| Ex Dividend Date | Mar 27 2026 |
| Dividend Pay Date | Apr 24 2026 |
| Days until Ex dividend | 5 days |
| Days until Dividend pay date | 23 days |
Does HUM pay a reliable dividends?
See HUM dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/30 11:14 |
| End of Day Share Price | 2026/03/30 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Humana Inc. is covered by 39 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |